600351_2023_#CSR_亚宝药业_亚宝药业2023年度社会责任报告_2024-04-26.pdfVIP

2023年度社会责任报告

1

关于本报告

尊敬的利益相关方，这是亚宝药业集团股份有限公司向社会公布

的2023年度企业社会责任报告。本报告详细记录了亚宝药业2023年

社会责任活动及成果，帮助股东、员工、政府、客户与消费者、合作

伙伴、公众等利益相关方全面了解本公司的社会责任实践信息。

时间范围

2023年1月1日至2023年12月31日。为增强报告可比性和完

整性，部分内容超出上述范围。

发布周期

本报告为年度报告

参考标准

亚宝药业在编制本报告过程中，遵循国家标准委《社会责任指南

GB/T36000-2015》、中国社会科学院《中国企业社会责任报告编制指

南》(CASS-CSR4.0)、全球报告倡议组织《GRI可持续发展报告指南

（G4版）》、联合国可持续发展目标（SDGs）。报告同时参考了《上海

证券交易所上市公司环境信息披露指引》及医药行业有关规定编制，

采纳了有关专家和利益相关方的意见及建议。

数据来源及可靠性保证

本报告数据来源于企业2023年度上市公司公告。公司承诺本报

告内容不存在任何虚假记载、误导性陈述或重大遗漏。

报告获取

亚宝药业集团股份有限公司在官方网站设置企业社会责任专栏，

您可以在亚宝药业官网（）下载本报告或阅读更多

企业社会责任信息。

1

关于本报告·······················································01

一、领导致辞·····················································03

二、年度大事记···················································06

三、关于亚宝·····················································10

（一）公司简介···············································10

（二）公司组织机构···········································12

（三）公司发展战略···········································12

（四）公司文化···············································13

（五）荣誉奖项···············································22

四、公司治理·····················································23

（一）规范运作···············································23

（二）信息披露···············································24

（三）投资者关系·············································24

（四）内部审计···············································25

（五）法律风险防控···········································26

（六）股东回报···············································26

五、经营篇：诚信经营，稳步发展···································27

（一）严控质量，生产放心产品·································28

（二）专注研发，提升创新能力·································31

（三）终端引领，畅通销售渠道·································32

六、环境篇：环保优先，绿色发展···················